Ebanga Injection, Powder, Lyophilized, For Solution
Product Images NDC 71655-578

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ebanga (NDC 71655-578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Manufacturing Operations Baltimore, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Kaplan-meier Curve For Overall Mortality In Palm Trial (Ebanga 01)

A line graph showing cumulative incidence of mortality (%) over 58 study days comparing Ebanga (blue line) and Control (red line). Mortality increases over time with the Control group showing higher cumulative incidence than the Ebanga group throughout the study period.*

FDA Label Image

Ebanga (Ebanga 02)

FDA Label Image

400 mg Vial Label (Ebanga 03)

Ebanga (ansuvimab-zykl) for Injection, 400 mg per vial, lyophilized powder for intravenous use. The label indicates it is a single-dose vial with instructions to reconstitute and dilute before administration. Storage instructions specify 2°C to 8°C, protecting from light, and caution against freezing or shaking. Manufacturer listed as Emergent Manufacturing Operations Baltimore LLC.*

FDA Label Image

Carton Containing 36x400 mg Vials (Ebanga 04)

Packaging label for Ebanga (ansuvimab-zykl) injection, 400 mg per vial, lyophilized powder for intravenous use. The label indicates contents of 36 vials per container. It is marked Rx only and includes manufacturer information for Emergent Manufacturing Operations Baltimore, LLC.*

FDA Label Image

Box Containing Single Carton (Ebanga 05)

Ebanga (ansuvimab-zykl) injection, lyophilized powder for intravenous use, 400 mg per vial. The packaging indicates a carton containing 36 vials of 400 mg each, labeled for intravenous administration. The labeler is Emergent Manufacturing Operations Baltimore, LLC, and the NDC is 71655-578. The product is prescription only and includes instructions for reconstitution and dilution.*

FDA Label Image

Box Containing 4 Cartons (Ebanga 06)

Packaging label for Ebanga (ansuvimab-zykl) injection, lyophilized powder for solution, 400 mg per vial for intravenous use. The label indicates the package contains 4 boxes each with 36 vials of 400 mg. The product is labeled for prescription use only, with no preservatives, and is manufactured by Emergent Manufacturing Operations Baltimore, LLC.*

FDA Label Image

Box Containing 8 Cartons (Ebanga 07)

Ebanga (ansuvimab-zykl) 400 mg per vial lyophilized powder for injection, for intravenous use. The folded carton label shows this product contains 8 x 36 vials of 400 mg each. It is labeled as Rx only and contains no preservative. The labeler is Emergent Manufacturing Operations Baltimore, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.